| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 313.18B | 302.50B | 287.56B | 293.36B | 291.27B | 285.52B |
| Gross Profit | 17.49B | 16.92B | 19.26B | 29.81B | 30.40B | 28.85B |
| EBITDA | 42.14B | 35.47B | 28.61B | 46.35B | 42.42B | 39.80B |
| Net Income | 13.32B | 8.75B | 7.83B | 20.79B | 16.76B | 15.32B |
Balance Sheet | ||||||
| Total Assets | 510.96B | 500.67B | 503.39B | 477.01B | 478.15B | 471.92B |
| Cash, Cash Equivalents and Short-Term Investments | 30.99B | 29.92B | 29.92B | 44.89B | 39.87B | 37.03B |
| Total Debt | 112.35B | 110.43B | 98.88B | 101.48B | 117.19B | 92.70B |
| Total Liabilities | 222.09B | 212.90B | 206.97B | 206.63B | 221.84B | 198.54B |
| Stockholders Equity | 286.87B | 285.95B | 294.65B | 266.70B | 252.54B | 269.57B |
Cash Flow | ||||||
| Free Cash Flow | 560.00M | -12.79B | -6.50B | 15.25B | 16.48B | 15.55B |
| Operating Cash Flow | 16.96B | 24.45B | 18.50B | 31.02B | 32.14B | 33.22B |
| Investing Cash Flow | -5.64B | -29.11B | -26.80B | -7.70B | -16.78B | -18.30B |
| Financing Cash Flow | -10.27B | 5.18B | -6.18B | -18.58B | -12.52B | -4.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥121.03B | 35.08 | ― | 3.57% | 3.00% | 5.43% | |
72 Outperform | ¥236.40B | 3.64 | 4.72% | 1.66% | 5.50% | -26.63% | |
70 Outperform | ¥25.89B | 10.21 | ― | 2.82% | 2.47% | 2.85% | |
69 Neutral | ¥6.08B | 9.76 | ― | 1.62% | 8.03% | 67.38% | |
64 Neutral | ¥374.82B | 11.50 | 5.53% | 4.35% | 22.07% | 86.12% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥633.93B | 5.81 | 7.44% | 2.10% | 5.58% | 114.23% |